Drug Trial Radar · NCT04247074
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
Last checked: Nov 20, 2026Latest source record: Sep 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
413
Actual
Start
Feb 10, 2020
Primary completion
Oct 2, 2020
Study completion Feb 26, 2021
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Jan 29, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.
Conditions
- Glabellar Frown Lines (GL)
- Lateral Canthal Lines (LCL)
Interventions
botulinum toxin neuromodulatorBiological
QM1114-DP will be injected into either the LCL, GL, or both the LCL and GL
PlaceboBiological
Placebo will be injected into either the LCL, GL, or both the LCL and GL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With a ≥ 2-grade Improvement From Baseline on the Glabellar Lines Investigator and Subject Assessments at Maximum FrownTime frame: Month 1
- Percentage of Subjects With a ≥ 2-grade Improvement From Baseline on the Lateral Canthal Lines Investigator and Subject Assessments at Maximum SmileTime frame: Month 1
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Clinical Testing of Beverly Hills
Encino, California
Ava MD
Santa Monica, California
Skin Care & Laser Physicians of Beverly Hills
West Hollywood, California
Center for Clinical and Cosmetic Research
Aventura, Florida
Baumann Cosmetic & Research Institute, Inc
Miami, Florida
Washington Institute of Dermatologic Laser Surgery
Chevy Chase, Maryland
Maryland Dermatology, Laser, Skin & Vein Institute
Hunt Valley, Maryland
Skin Specialists, PC
Omaha, Nebraska
Lorenc Aesthetic Plastic Surgery Center
New York, New York
Elite Aesthetic Research
Cincinnati, Ohio
The Westlake Dermatology Clinical Research
Austin, Texas
Bertucci Medspa, Inc
Woodbridge, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.